Dr. Wen Xue to speak at RNA Therapeutics Symposium: From Concept to Clinic
June 21-23, 2023
Registration is open for the 5th annul symposium at UMass Chan Medical School.
- The RNA World Across Kingdoms
- Mechanisms of RNA Pathways
- Oligonucleotide Drugs, Modifications, and Delivery
- mRNA Therapeutics
- Translating Discoveries into the Clinic
Dr. Shengdar Q. Tsai joins a panel discussion at Rare Disease Day at NIH
February 28, 2023
Dr. Shengdar Q. Tsai of St. Jude Children’s Research Hospital will join a panel discussion on genetics, gene-targeted therapies, and diversity, equity, and inclusion at Rare Disease Day at NIH on February 28th. The speakers on this panel will discuss obstacles to realizing the benefits of gene-targeted technologies in an equitable way across diverse groups and the efforts required to prevent inequity and health disparities in this relatively new field.
Jill Banfield Wins the 2023 van Leeuwenhoek Medal
IGI News, February 9, 2023
Innovative Genomics Institute Director of Microbiology Jill Banfield has been awarded the 2023 van Leeuwenhoek Medal for her contribution to the understanding of microbial communities and interactions between microbes and the environment. The van Leeuwenhoek Medal is awarded once every ten to twelve years by the Royal Netherlands Society for Microbiology (KNVM) to a recognize remarkable contributions to the field of microbiology and impact on society.
NeuShen Therapeutics funds ALS research at UMass Chan Medical School
UMass Chan Medical School has signed a three-year sponsored research agreement with NeuShen Therapeutics Inc. to investigate a gene therapy treatment for amyotrophic lateral sclerosis. Jun Xie, PhD, associate professor of microbiology & physiological systems, will serve as principal investigator of the program. Co-leading the program is Guangping Gao, PhD, professor of microbiology & physiological systems, director of the Horae Gene Therapy Center and co-director of the Li Weibo Institute for Rare Diseases Research at UMass Chan.